[{"address1": "8584, Washington Street", "address2": "Suite 127", "city": "Chagrin Falls", "state": "OH", "zip": "44023", "country": "United States", "phone": "213 642 9268", "website": "https://novaccessglobal.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "NovAccess Global Inc., a biopharmaceutical company, develops novel immunotherapies to treat brain tumor patients in the United States. The company specializes in cutting-edge research related to utilizing a patient's immune system to attack the cancer. NovAccess Global Inc. was incorporated in 1997 and is headquartered in Chagrin Falls, Ohio.", "fullTimeEmployees": 2, "companyOfficers": [{"maxAge": 1, "name": "Dr. Dwain K. Morris-Irvin M.P.H., MPH, Ph.D.", "age": 56, "title": "CEO & Director", "yearBorn": 1967, "fiscalYear": 2022, "totalPay": 221492, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Neil J. Laird", "age": 70, "title": "Chief Financial Officer", "yearBorn": 1953, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Christopher  Wheeler Ph.D.", "title": "President of Stemvax Therapeutics", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.025, "open": 0.025, "dayLow": 0.025, "dayHigh": 0.025, "regularMarketPreviousClose": 0.025, "regularMarketOpen": 0.025, "regularMarketDayLow": 0.025, "regularMarketDayHigh": 0.025, "beta": 1.519, "volume": 11005, "regularMarketVolume": 11005, "averageVolume": 263919, "averageVolume10days": 480800, "averageDailyVolume10Day": 480800, "marketCap": 598890, "fiftyTwoWeekLow": 0.0135, "fiftyTwoWeekHigh": 0.245, "fiftyDayAverage": 0.0254138, "twoHundredDayAverage": 0.08517835, "currency": "USD", "enterpriseValue": 7313036, "floatShares": 13762018, "sharesOutstanding": 23955500, "heldPercentInsiders": 0.45136002, "heldPercentInstitutions": 0.08124, "impliedSharesOutstanding": 23955600, "bookValue": -0.51, "lastFiscalYearEnd": 1664496000, "nextFiscalYearEnd": 1696032000, "mostRecentQuarter": 1688083200, "netIncomeToCommon": -3015041, "trailingEps": -0.15, "lastSplitFactor": "1:1000", "lastSplitDate": 1598400000, "52WeekChange": -0.875, "SandP52WeekChange": 0.20883334, "exchange": "PNK", "quoteType": "EQUITY", "symbol": "XSNX", "underlyingSymbol": "XSNX", "shortName": "NOVACCESS GLOBAL INC", "longName": "NovAccess Global Inc.", "firstTradeDateEpochUtc": 906384600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "efe54aee-8917-3127-bcfe-6bde48c6bee3", "messageBoardId": "finmb_3184113", "gmtOffSetMilliseconds": -18000000, "currentPrice": 0.025, "recommendationKey": "none", "totalCash": 61464, "totalCashPerShare": 0.003, "totalDebt": 2089000, "quickRatio": 0.02, "currentRatio": 0.028, "returnOnAssets": -8.01652, "freeCashflow": 372144, "operatingCashflow": -667321, "financialCurrency": "USD", "trailingPegRatio": null}]